Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2008 4
2010 3
2011 2
2012 2
2013 7
2014 6
2015 4
2016 1
2017 6
2018 4
2019 6
2020 4
2021 4
2022 5
2023 3
2024 2
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.
Rosmarin D, Passeron T, Pandya AG, Grimes P, Harris JE, Desai SR, Lebwohl M, Ruer-Mulard M, Seneschal J, Wolkerstorfer A, Kornacki D, Sun K, Butler K, Ezzedine K; TRuE-V Study Group. Rosmarin D, et al. N Engl J Med. 2022 Oct 20;387(16):1445-1455. doi: 10.1056/NEJMoa2118828. N Engl J Med. 2022. PMID: 36260792 Clinical Trial.
Ipilimumab-induced severe meningoradiculitis.
Lacour M, Grangeon L, Flament J, Duval-Modeste AB, Zaréa A, Guillaume M, Lefaucheur R. Lacour M, et al. Among authors: duval modeste ab. J Clin Neurosci. 2019 Apr;62:246-247. doi: 10.1016/j.jocn.2018.12.009. Epub 2018 Dec 28. J Clin Neurosci. 2019. PMID: 30598268 No abstract available.
Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma.
Rischin D, Porceddu S, Day F, Brungs DP, Christie H, Jackson JE, Stein BN, Su YB, Ladwa R, Adams G, Bowyer SE, Otty Z, Yamazaki N, Bossi P, Challapalli A, Hauschild A, Lim AM, Patel VA, Walker JL, De Liz Vassen Schurmann M, Queirolo P, Cañueto J, Ferreira da Silva FA, Stratigos A, Guminski A, Lin C, Damian F, Flatz L, Taylor AE, Carr DR, Harris S, Kirtbaya D, Quereux G, Rutkowski P, Basset-Seguin N, Khushalani NI, Robert C, Ju H, Joseph C, Bansal S, Chen CI, Seebach F, Yoo SY, Lowy I, Goncalves P, Fury MG; C-POST Trial Investigators. Rischin D, et al. N Engl J Med. 2025 Aug 21;393(8):774-785. doi: 10.1056/NEJMoa2502449. Epub 2025 May 31. N Engl J Med. 2025. PMID: 40454639 Clinical Trial.
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.
Griffiths CE, Reich K, Lebwohl M, van de Kerkhof P, Paul C, Menter A, Cameron GS, Erickson J, Zhang L, Secrest RJ, Ball S, Braun DK, Osuntokun OO, Heffernan MP, Nickoloff BJ, Papp K; UNCOVER-2 and UNCOVER-3 investigators. Griffiths CE, et al. Lancet. 2015 Aug 8;386(9993):541-51. doi: 10.1016/S0140-6736(15)60125-8. Epub 2015 Jun 10. Lancet. 2015. PMID: 26072109 Clinical Trial.
[Imatinib-induced DRESS].
Goldman J, Duval-Modeste AB, Lambert A, Contentin N, Courville P, Musette P, Joly P. Goldman J, et al. Among authors: duval modeste ab. Ann Dermatol Venereol. 2008 May;135(5):393-6. doi: 10.1016/j.annder.2007.10.007. Epub 2008 Apr 21. Ann Dermatol Venereol. 2008. PMID: 18457727 French.
Efficacy and Tolerability of Tebentafusp in Metastatic Uveal Melanoma: A Real-life Retrospective Multicentre Study.
Vitek L, Goronflot T, Dutriaux C, Deleuze A, Le Corre Y, Duval-Modeste AB, Fresnard C, Jeudy G, Lamoureux A, Gaudy-Marqueste C, Legoupil D, Baroudjian B, L'Orphelin JM, Peuvrel L, Khammari A, Mortier L, Quereux G. Vitek L, et al. Among authors: duval modeste ab. Acta Derm Venereol. 2024 Dec 12;104:adv41297. doi: 10.2340/actadv.v104.41297. Acta Derm Venereol. 2024. PMID: 39670438 Free PMC article.
Increased risk of cutaneous squamous cell carcinomas in patients with Sézary syndrome: A nationwide multicenter retrospective study.
Guillon L, Ram-Wolff C, Boulinguez S, Beylot-Barry M, D'Incan M, Adamski H, Faiz S, Le Corre Y, Dalle S, Amatore F, Cornillault A, Chaby G, Duval-Modeste AB, Dalac S, Oro S, Montaudié H, Nardin C, Lenormand C, Maubec E, Stoebner PE, Dereure O; French Cutaneous Lymphomas Study Group. Guillon L, et al. Among authors: duval modeste ab. J Am Acad Dermatol. 2025 Jul;93(1):287-289. doi: 10.1016/j.jaad.2025.03.049. Epub 2025 Mar 22. J Am Acad Dermatol. 2025. PMID: 40127782 Free article. No abstract available.
[Hypopigmented mycosis fungoides].
Cordel N, Duval-Modeste AB, Courville P, Joly P. Cordel N, et al. Among authors: duval modeste ab. Ann Dermatol Venereol. 2005 May;132(5):455-7. doi: 10.1016/s0151-9638(05)79307-8. Ann Dermatol Venereol. 2005. PMID: 15988357 French.
Clostridium difficile infection and immune checkpoint inhibitor-induced colitis in melanoma: 18 cases and a review of the literature.
Vuillamy C, Arnault JP, Fumery M, Mortier L, Monestier S, Mansard S, Bens G, Duval-Modeste AB, Funck-Brentano E, Jeudy G, Machet L, Chaby G, Dadban A, Lok C; Groupe de Cancérologie Cutanée de la Société Française de Dermatologie. Vuillamy C, et al. Among authors: duval modeste ab. Melanoma Res. 2023 Jun 1;33(3):192-198. doi: 10.1097/CMR.0000000000000878. Epub 2023 Mar 27. Melanoma Res. 2023. PMID: 36995276 Free PMC article. Review.
58 results